LUNDBERG MAGNUS 4
4 · ONYX PHARMACEUTICALS INC · Filed Apr 11, 2013
Insider Transaction Report
Form 4
LUNDBERG MAGNUS
Director
Transactions
- Exercise/Conversion
Common Stock
2013-04-11$16.28/sh+10,000$162,800→ 24,216 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-04-11−10,000→ 0 totalExercise: $16.28Exp: 2016-06-08→ Common Stock (10,000 underlying) - Sale
Common Stock
2013-04-11$96.00/sh−10,000$960,000→ 14,216 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]Fully vested.